Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
ipo
7
×
life sciences
national blog main
national top stories
san francisco blog main
san francisco top stories
7
×
boston top stories
boulder/denver blog main
boulder/denver top stories
cancer
clinical trials
detroit blog main
detroit top stories
fda
indiana blog main
indiana top stories
national
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
venture capital
biogen
novartis
san francisco
sanofi
astrazeneca
cancer drugs
cancer immunotherapy
celgene
What
ipo
7
×
medicines
bio
cancer
new
roundup
biotechs
covid
firms
life
million
proteins
research
revolution
science
sciences
therapeutics
way
week
years
acquisitions
activity
allogene
announced
approvals
biogen
cancer’s
ceo
chose
clamped
close
club
collabs
companies
company
continued
crispr
crop
daniel
deal
Language
unset
Current search:
ipo
×
ipo
×
" san francisco top stories "
×
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com
5 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way
@xconomy.com
6 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M